Eteplirsen (Exondys 51) for Duchenne Muscular Dystrophy (DMD) approved
September 19, 2016 – This post presents below a virtually unedited announcement by the American Food & Drug Administration (FDA) concerning Duchenne Muscular Dystrophy (DMD) therapy option which gives much hope for at least some of the affected patients. However, be …
Eteplirsen (Exondys 51) for Duchenne Muscular Dystrophy (DMD) approved Read more »